Claims for Patent: 7,928,064

✉ Email this page to a colleague

Summary for Patent: 7,928,064

Title:	Transgenically produced antithrombin III
Abstract:	This invention relates to transgenically produced human Antithrombin III (tgATIII). The human ATIII produced by the transgenic process of the present invention has a monosaccharide composition which comprises N-acetylgalactosamine (GalNAc) along with fucose, N-acetylglucosamine, galactose, mannose, and N-acetylneuraminic acid/N-glycolyneuraminic acid. The monosaccharide composition differs with that of plasma derived ATIII (phATIII). It has been found that tgATIII has an increased clearance rate when compared to phATIII.
Inventor(s):	Paul DiTullio, Harry M. Meade, Edward S. Cole
Assignee:	rEVO Biologics Inc
Application Number:	US11/284,585

Details for Patent 7,928,064

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Revo Biologics, Inc.	ATRYN	antithrombin (recombinant)	For Injection	125284	February 06, 2009	⤷ Get Started Free	2025-11-14
Revo Biologics, Inc.	ATRYN	antithrombin (recombinant)	For Injection	125284	April 11, 2014	⤷ Get Started Free	2025-11-14
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 7,928,064

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	9626268	⤷ Get Started Free
United States of America	7019193	⤷ Get Started Free
United States of America	6441145	⤷ Get Started Free
United States of America	5843705	⤷ Get Started Free
United States of America	2008176786	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.